Neuronetics (STIM) Income towards Parent Company (2017 - 2026)
Neuronetics' (STIM) quarterly Income towards Parent Company came in at -$3.6 million in Q2 2026, up 63.84% year-over-year from -$2.2 million in Q2 2025, and up 67.8% quarter-over-quarter from -$11.3 million in Q1 2026.
Analysis
Neuronetics (STIM) Income towards Parent Company (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Income towards Parent Company for 10 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 63.84% year-over-year to -$3.6 million in Q2 2026; TTM through Jun 2026 was -$31.8 million, a 30.39% increase from a year earlier, with the FY2025 full-year figure at -$39.9 million, up 4.77% from the prior year.
- Income towards Parent Company was -$3.6 million for Q2 2026 at Neuronetics, up from -$11.3 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at -$3.6 million in Q2 2026 and troughed at -$13.2 million in Q4 2024.
- A 5-year average of -$9.6 million and a median of -$9.8 million in 2025 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company plunged 110.96% in 2024 and soared 63.84% in 2026, its largest moves.
- Over 5 years, Income towards Parent Company stood at -$8.9 million in 2022, then gained by 29.85% to -$6.3 million in 2023, then sank by 110.96% to -$13.2 million in 2024, then soared by 44.36% to -$7.4 million in 2025, then jumped by 50.74% to -$3.6 million in 2026.
- The last three Income towards Parent Company figures came in at -$3.6 million (Q2 2026), -$11.3 million (Q1 2026), and -$7.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn |
| 10 | Neuronetics | 209.15 Mn | 189.72 Mn | 21.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.63 Mn |
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -7.36 Mn |
| Sep 30, 2025 | -9.53 Mn |
| Jun 30, 2025 | -10.03 Mn |
| Mar 31, 2025 | -12.94 Mn |
| Dec 31, 2024 | -13.23 Mn |
| Sep 30, 2024 | -9.45 Mn |
| Jun 30, 2024 | -10.49 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.27 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.49 Mn |
| Mar 31, 2023 | -11.16 Mn |
| Dec 31, 2022 | -8.94 Mn |
| Sep 30, 2022 | -8.52 Mn |
| Jun 30, 2022 | -10.80 Mn |
| Mar 31, 2022 | -11.11 Mn |
| Dec 31, 2021 | -7.97 Mn |
| Sep 30, 2021 | -8.18 Mn |